Now showing items 1-4 of 4

    • Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. 

      Mugo, Nelly; Lingappa, Jairam R.; Kahle, Erin; Mujugira, Andrew; Magaret, Amalia; Baeten, Jared; Bukusi, Elizabeth A.; Cohen, Craig R.; Katabira, Elly T.; Ronald, Allan; Kiarie, James; Farquhar, Guy; Stewart, Grace John; Makhema, Joseph; Essex, M.; Were, Edwin; Fife, Kenneth (Public Library of Science, 2009-04-30)
      Background: The Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled trial of daily acyclovir for genital herpes (HSV-2) suppression among HIV-1/HSV-2 co-infected persons to reduce ...
    • The international HIV dementia scale: a new rapid screening test for HIV dementia. 

      Sacktor, Ned C.; Wong, Matthew; Nakasujja, Noeline; Skolasky, Richard L.; Selnes, Ola A.; Musisi, Seggane; Robertson, Kevin; McArthur, Justin C.; Ronald, Allan; Katabira, Elly T. (Lippincott Williams & Wilkins, 2005)
      Objective: HIV dementia is an important neurological complication of advanced HIV infection. The use of a cross-cultural screening test to detect HIV dementia within the international community is critical for diagnosing ...
    • The liver in HIV in Africa 

      Ocama, Ponsiano; Feld, Jordan J; Ronald, Allan (International Medical Press, 2005)
      As access to antiretroviral therapy improves across the African continent, liver disease is emerging as an important cause of morbidity and mortality among HIV-infected individuals. Although coinfection with hepatitis B ...
    • The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda 

      Ocama, Ponsiano; Katwere, Michael; Piloya, Theresa; Feld, Jordan; Opio, Kenneth C.; Katabira, Elly; Thomas, David; Colebunders, Robert; Ronald, Allan (Makerere University Medical School, 2008-03)
      Background: Liver diseases are common in patients with HIV due to viral hepatitis B and C co-infections, opportunistic infections or malignancies, antiretroviral drugs and drugs for opportunistic infections. Objective: To ...